Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
782.75
709.26
522.05
519.87
563.18
411.95
464.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
782.75
709.26
522.05
519.87
563.18
411.95
464.91
Raw Material Cost
501.87
425.26
299.72
387.95
313.27
259.50
307.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-64.81
-1.00
36.08
-112.50
26.73
-13.14
-14.48
Employee Cost
80.08
64.15
53.82
51.02
41.17
39.35
35.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
86.35
73.45
53.70
55.04
39.39
33.64
34.84
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
40.26
30.78
24.25
24.04
21.51
12.67
11.68
Total Expenditure (Excl Depreciation)
643.75
592.64
467.57
405.55
442.07
332.02
374.82
Operating Profit (PBDIT) excl Other Income
139.00
116.62
54.48
114.32
121.11
79.93
90.09
Other Income
6.22
4.46
4.91
5.20
3.45
5.11
3.40
Operating Profit (PBDIT)
145.22
121.08
59.39
119.52
124.56
85.04
93.49
Interest
18.54
23.46
21.91
18.88
11.16
12.21
11.87
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
126.68
97.62
37.48
100.64
113.40
72.83
81.62
Depreciation
34.34
31.52
32.13
32.15
22.28
22.07
19.27
Profit Before Tax
92.34
66.11
5.35
68.50
91.12
50.76
62.35
Tax
24.94
16.91
1.47
0.62
30.16
18.07
20.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.40
49.20
3.88
67.88
60.96
32.69
41.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.40
49.20
3.88
67.88
60.96
32.69
41.45
Share in Profit of Associates
1.74
0.63
-10.94
-5.66
1.56
-1.11
-1.41
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
69.14
49.83
-7.06
62.22
62.53
31.57
40.05
Equity Capital
8.87
8.47
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
630.78
527.86
452.06
461.82
402.06
339.77
313.45
Earnings per share (EPS)
7.79
5.88
-0.83
7.35
7.38
3.73
4.73
Diluted Earnings per share
8.16
5.89
-0.83
7.35
7.39
3.73
4.73
Operating Profit Margin (Excl OI)
17.76%
16.44%
10.44%
21.99%
21.5%
19.4%
19.38%
Gross Profit Margin
16.18%
13.76%
7.18%
19.36%
20.14%
17.68%
17.56%
PAT Margin
8.61%
6.94%
0.74%
13.06%
10.82%
7.94%
8.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 10.36% vs 35.86% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 38.75% vs 805.81% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 19.19% vs 114.06% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -20.97% vs 7.07% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of SMS Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
782.75
1,859.80
-1,077.05
-57.91%
Other Operating Income
0.00
0.00
0.00
Total Operating income
782.75
1,859.80
-1,077.05
-57.91%
Raw Material Cost
501.87
882.60
-380.73
-43.14%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-64.81
-45.30
-19.51
-43.07%
Employee Cost
80.08
247.10
-167.02
-67.59%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
86.35
0.00
86.35
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
40.26
447.00
-406.74
-90.99%
Total Expenditure (Excl Depreciation)
643.75
1,531.40
-887.65
-57.96%
Operating Profit (PBDIT) excl Other Income
139.00
328.40
-189.40
-57.67%
Other Income
6.22
5.00
1.22
24.40%
Operating Profit (PBDIT)
145.22
333.40
-188.18
-56.44%
Interest
18.54
75.20
-56.66
-75.35%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
126.68
258.20
-131.52
-50.94%
Depreciation
34.34
134.40
-100.06
-74.45%
Profit Before Tax
92.34
123.80
-31.46
-25.41%
Tax
24.94
33.00
-8.06
-24.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
67.40
90.80
-23.40
-25.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
67.40
90.80
-23.40
-25.77%
Share in Profit of Associates
1.74
0.00
1.74
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.14
90.80
-21.66
-23.85%
Equity Capital
8.87
24.70
-15.83
-64.09%
Face Value
1.00
2.00
0.00
Reserves
630.78
1,237.60
-606.82
-49.03%
Earnings per share (EPS)
7.79
7.35
0.44
5.99%
Diluted Earnings per share
8.16
7.36
0.80
10.87%
Operating Profit Margin (Excl OI)
17.76%
17.81%
0.00
-0.05%
Gross Profit Margin
16.18%
14.01%
0.00
2.17%
PAT Margin
8.61%
4.93%
0.00
3.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 782.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.36% vs 35.86% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 69.14 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 38.75% vs 805.81% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 139.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.19% vs 114.06% in Mar 2024
Annual - Interest
Interest 18.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -20.97% vs 7.07% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.76%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
